Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: August 28th 2024 | Updated: September 13th 2024
Illuminating the Future: Dr Kristen Whitney on What's Next for Dermoscopy
Published: September 6th 2024 | Updated: September 13th 2024
Tailoring Treatment for Alopecia Areata
Published: September 6th 2024 | Updated: September 13th 2024
Future Directions for Type 2 Inflammation Management
Published: September 6th 2024 | Updated: September 13th 2024
Addressing Unmet Needs and Emerging Agents
Published: August 30th 2024 | Updated: September 13th 2024
Biomarkers as Tools in Management of Type 2 Inflammation